Dyax (DYAX) Inventory Turnover Ratio, from third quarter 2015 to third quarter 2014, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Dyax Corp  (DYAX)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Dyax Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Dyax Corp inventory turnover ratio, the Dyax Corp's ability to sell and replace its inventory in the third quarter 2015, sequentially increased to 3.27 in the third quarter 2015, a new company high. Average inventory processing period, for the Dyax in Sep 30 2015 quarter, has decreased to 112 days, compare to 122 days, in the Jun 30 2015 quarter.

Within Healthcare sector 125 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1229 in the second quarter 2015, to 1434.

DYAX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Dyax Corp Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

DYAX Inventory Turnover Ratio (Sep 30 2015)
III. Quarter		 (Jun 30 2015)
II. Quarter		 (Mar 31 2015)
I. Quarter		 (Dec 31 2014)
IV. Quarter		 (Sep 30 2014)
III. Quarter
Y / Y Inventory Growth 21.68 % 3.72 % 55.95 % 59.32 % 27.76 %
Y / Y Cost of Sales Growth 105.42 % 270.77 % 381.91 % 240.13 % 140.97 %
Inventory Turnover Ratio (TTM) 3.27 2.99 2.36 1.81 1.37
DYAX's Total Ranking # 1434 # 1229 # 1225 # 1229 # 1230
Average inventory processing period 112 122 154 202 267
Seq. Inventory Growth 42.67 % -27.07 % 1.8 % 14.87 % 21.62 %
Seq. Cost of Sales Growth -1.41 % -4.44 % 21.95 % 78.79 % 77.95 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Laboratories Industry # 11
Healthcare Sector # 126
Overall Market # 1434

Inventory Turnover Ratio Statistics
High Average Low
3.27 1.21 0.1
(Sep 30 2015)   (Mar 31 2012)



DYAX Company Profile >> Back to DYAX Efficiency Comparisons >> Compare DYAX Inventory Turnover Ratio to its Competitors

Financial Statements
Dyax's Inventories $ 5 Millions Visit DYAX's Balance sheet
Dyax's Cost of Revenues TTM $ 14 Millions Visit DYAX's Income Statement
What are DYAX's Sales? Visit DYAX's Sales by Segment

Other Inventory Turnover Ratios
Dyax's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Laboratories Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
DYAX's Inventory Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for DYAX's Competitors
Inventory Turnover Ratio for DYAX's Suppliers
Inventory Turnover Ratio for DYAX's Customers

You may also want to know
DYAX's Sales Growth Rates DYAX's Pe Price to earnings ratio DYAX's Receivables Turnover Ratio DYAX's Stock Quote
DYAX's Net Income Growth Rates DYAX's Ps Price to Sales ratio DYAX's Sales per Employee DYAX's Asset Turnover Ratio
DYAX's Net Margin DYAX's Pb Price to Book ratio DYAX's Financial Strength Ratios DYAX's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2015, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2015 Inventories at quarter ending Sep 30 2015
Rockwell Medical inc   8.09 $ 46.207  Millions$ 6  Millions
Ufp Technologies Inc   7.90 $ 103.051  Millions$ 13  Millions
Inotiv Inc   7.88 $ 12.525  Millions$ 2  Millions
China Health Industries Holdings Inc   7.53 $ 6.495  Millions$ 1  Millions
Kewaunee Scientific Corporation  7.49 $ 98.991  Millions$ 13  Millions
Infusystem Holdings Inc  7.10 $ 13.392  Millions$ 2  Millions
Lifemd Inc   7.01 $ 0.255  Millions$ 0  Millions
Ligand Pharmaceuticals Incorporated  6.98 $ 8.927  Millions$ 1  Millions
Avanos Medical Inc   6.85 $ 2,094.100  Millions$ 306  Millions
Mayfair Gold Corp   6.55 $ 2.173  Millions$ 0  Millions
Global Cord Blood Corp  6.47 $ 26.929  Millions$ 4  Millions
Genmark Diagnostics Inc   6.32 $ 14.165  Millions$ 2  Millions
Musclepharm Corporation  6.28 $ 108.566  Millions$ 17  Millions
Charles River Laboratories International inc   6.26 $ 568.216  Millions$ 91  Millions
Enovis Corp  6.24 $ 2,801.749  Millions$ 449  Millions
Steris Plc  6.19 $ 1,101.063  Millions$ 178  Millions
Carlisle Companies Incorporated  6.14 $ 2,261.700  Millions$ 368  Millions
Fuse Medical Inc   6.14 $ 0.686  Millions$ 0  Millions
Scienture Holdings Inc   5.90 $ 1.441  Millions$ 0  Millions
Advanced Container Technologies Inc   5.80 $ 0.511  Millions$ 0  Millions
Omnova Solutions Inc  5.78 $ 540.400  Millions$ 93  Millions
Patterson Companies Inc   5.72 $ 3,488.944  Millions$ 610  Millions
Hill rom Holdings Inc   5.70 $ 1,107.900  Millions$ 194  Millions
Invacare Holdings Corporation  5.61 $ 852.867  Millions$ 152  Millions
Vaso Corporation  5.61 $ 11.427  Millions$ 2  Millions
Henry Schein Inc   5.59 $ 7,503.452  Millions$ 1,341  Millions
Integrated Biopharma Inc  5.54 $ 33.944  Millions$ 6  Millions
Assertio Holdings inc   5.47 $ 50.137  Millions$ 9  Millions
Teligent Inc   5.44 $ 21.153  Millions$ 4  Millions
Veru Inc   5.41 $ 13.635  Millions$ 3  Millions

Date modified: 2026-08-29T13:43:07+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.